CureToday: UC enrolling patients for glioblastoma trial

A new clinical trial at the University of Cincinnati is studying the effectiveness of a new two-pronged immunotherapy treatment procedure to treat the most aggressive and deadly type of brain tumors, called glioblastomas. Originating from healthy brain cells, glioblastomas can form in any area of the brain.

Soma Sengupta, MD, PhD, said the trial will administer two immunotherapy drugs in tandem with each other. She noted previous research has shown a single-arm immunotherapy treatment has not been effective, leading to the combination therapy being tested in the trial.

In collaboration with the Dana-Farber Cancer Insitute in Boston, a teaching affiliate of Harvard Medical School, researchers aim to enroll 24 patients in the Phase 1 study.

Read the article.

Read more about the trial.

For more trial and enrollment information, contact Alex Love at lovea4@ucmail.uc.edu.

Featured photo at top of glioblastoma cells in culture courtesy of National Cancer Institute.

Related Stories

1

Doctor urges caution when clearing snow

January 26, 2026

The University of Cincinnati's Rani Nasser, MD, was featured in a Fox 19 report discussing ways to stay safe when shoveling snow after winter storms.

3

UC alum making historic waves

January 23, 2026

Christopher Bak is a UC Lindner alum making history. His gold at the 2025 World Championships was his third win and fifth time medaling overall. Bak’s achievements put him in the running for World Rowing’s Men’s Crew of the Year, a competitive award with only three nominees across the globe. Winners will be announced at the World Rowing Awards hosted at Switzerland’s Olympic Museum on Jan. 24. Not only is Bak in the running, but his coach, a UC faculty member, is nominated as well. Mark Oria, assistant professor of research at the UC College of Medicine, is one of four finalists for World Rowing’s Coach of the Year. The two have been working together since Oria joined the coaching team at UC back in 2017.